
Get full access for you and your coworkers.
Start a free company trial todayAlready a member? Log in.
After the US health authorities approved a new production setup at Horizon Therapeutics, which holds the rights to Genmab's drug Tepezza, the company expects that current supply-related issues will soon be resolved.
Already a member? Log in.